Abstract:
The present invention includes compounds of the formula wherein: X is hydrogen or halide; R is hydrogen, acyl, or a hydroxy protecting group; R is hydrogen, hydroxyl, or âOR wherein R is a substituted or unsubstituted moiety selected from the group consisting of C -C alkyl, C -C alkenyl, C -C alkynyl, aryl, heterocyclo, aryl(C -C )alkyl, aryl(C -C )alkenyl, aryl(C -C )alkynyl, heterocyclo(C -C )alkyl, heterocyclo(C -C )alkenyl, and heterocyclo(C -C )alkynyl; R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of methyl; C -C alkyl, C -C alkenyl, C -C alkynyl, aryl, heterocyclo, aryl(C -C )alkyl, aryl(C -C )alkenyl, aryl(C -C )alkynyl, heterocyclo(C -C )alkyl, heterocyclo(C -C )alkenyl, and heterocyclo(C -C )alkynyl; and, R is hydrogen or a substituted or unsubstituted moiety wherein the moiety is selected from the group consisting of C -C alkyl, C -C alkenyl, C -C alkynyl, aryl, heterocyclo, aryl(C -C )alkyl, aryl(C -C )alkenyl, aryl(C -C )alkynyl, heterocyclo(C -C )alkyl, heterocyclo(C -C )alkenyl, and heterocyclo(C -C )alkynyl; and the pharmaceutically acceptable salts, esters and pro-drug forms thereof. These compounds possess anti-infective activity and are useful for the treatment of bacterial and protozoal infections.